| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |